Procainamide

Procainamide Hydrochloride Injection USP

100 MG / ML SolutionCanadaMarketedAuthorised 31 Dec 1995

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

ProcamideBrazil · Zambon Laboratórios Farmacêuticos Ltda.Same substance
Biocoryl 100 MG/ML Solucion InyectableSpain · 1000 mg · solución inyectable · Mana Pharma S.L.Same substance
Procainamide HydrochlorideUnited States · 100MG/ML, 500MG/ML · injectable · Watson LabsSame substance
Procainamide HCLUnited States · 100MG/ML, 500MG/ML · Injectable · Quad PharmsSame substance
PronestylUnited States · 100MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 500MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · injectable · ApotheconSame substance

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Procainamide

Procainamide Hydrochloride Injection USP

100 MG / ML SolutionCanadaMarketedAuthorised 31 Dec 1995

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Procainamide
Strength: 100 MG / ML
Dosage form: Solution
Route: Intramuscular, Intravenous
Register: Canada (Health Canada)
Status: Marketed
Authorised: 31 Dec 1995
Registration: DIN 02184486
Marketing authorisation holder: Sandoz Canada Incorporated
ATC code: C01BA02
Group: Cardiovascular system
Supply: PRESCRIPTION

Apo-Procainamide Cap 500MGProcainamide · 500 MG · CapsuleCanadaCancelled

Procainamide-250 Cap 250MGProcainamide · 250 MG · CapsuleCanadaCancelled

Procainamide-375 Cap 375MGProcainamide · 375 MG · CapsuleCanadaCancelled

Procainamide-500 Cap 500MGProcainamide · 500 MG · CapsuleCanadaCancelled

Procan SRProcainamide · 500 MG · Tablet (Extended-Release)CanadaCancelled

Procan SRProcainamide · 750 MG · Tablet (Extended-Release)CanadaCancelled

Procan SRProcainamide · 250 MG · Tablet (Extended-Release)CanadaCancelled

Pronestyl Cap 250MGProcainamide · 250 MG · CapsuleCanadaCancelled

Pronestyl Cap 375MGProcainamide · 375 MG · CapsuleCanadaCancelled

Pronestyl Cap 500MGProcainamide · 500 MG · CapsuleCanadaCancelled